Head and neck cancer surgery in COVID-19 pandemic in Northern Italy

Oral Oncol. 2020 Aug:107:104835. doi: 10.1016/j.oraloncology.2020.104835. Epub 2020 May 30.

Abstract

  1. COVID-2019 pandemic represents a great challenge both in itself and for time-sensitive diseases.

  2. Head and neck cancer surgery is a high risk procedure for COVID-19.

  3. Possibility of SARS-CoV-2 false negative at pre-operative evaluation in asymptomatic subjects should not let guard down in the post-operative time.

Keywords: COVID-19; Coronavirus; Head and neck cancer; Head and neck surgery.

Publication types

  • Letter

MeSH terms

  • Aged
  • Betacoronavirus / genetics
  • Betacoronavirus / isolation & purification*
  • Betacoronavirus / pathogenicity
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques / standards*
  • Clinical Laboratory Techniques / statistics & numerical data
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / transmission
  • False Negative Reactions
  • Female
  • Head and Neck Neoplasms / surgery*
  • Humans
  • Infection Control / instrumentation
  • Infection Control / standards
  • Infectious Disease Transmission, Patient-to-Professional / prevention & control
  • Infectious Disease Transmission, Professional-to-Patient / prevention & control
  • Italy / epidemiology
  • Male
  • Nasopharynx / surgery
  • Nasopharynx / virology
  • Otorhinolaryngologic Surgical Procedures / standards*
  • Otorhinolaryngologic Surgical Procedures / statistics & numerical data
  • Pandemics / prevention & control*
  • Personal Protective Equipment / standards
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / transmission
  • Preoperative Care / instrumentation
  • Preoperative Care / standards
  • Preoperative Care / statistics & numerical data
  • RNA, Viral / isolation & purification
  • SARS-CoV-2
  • Surgical Oncology / standards*
  • Tertiary Care Centers / statistics & numerical data
  • Time-to-Treatment

Substances

  • RNA, Viral